Retrospective Study
Copyright ©The Author(s) 2016.
World J Transplant. Jun 24, 2016; 6(2): 411-422
Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.411
Table 1 Multivariable analysis of prognostic factors for overall and disease-free survival
Overall survival
Disease-free survival
Multivariable analysisHR95%CIPHR95% CIP
Variables
AFP> 400 ng/mL1.1450.543-2.4180.7221.0030.556-1.8110.991
PET/CTPositive2.6521.384-5.0850.0032.5171.481-4.2790.001
Tumor number> 30.6470.294-1.4250.2800.8140.425-1.5570.534
Maximum tumor size> 5 cm0.6960.307-1.5800.3861.5510.836-2.8770.164
Total tumor size> 10 cm2.9091.230-6.8800.0153.0031.536-5.8700.001
Differentiation1III-IV1.2060.616-2.3580.5851.0100.594-1.7170.972
Microvascular invasionPresent1.2690.522-3.0840.5992.1481.064-4.3360.033
Capsule formationPresent0.4390.166-1.1620.0970.7370.353- 1.5420.418
Major vessel invasionPresent2.0170.829-4.9050.1221.7120.850-3.4490.132
Ductal invasionPresent0.9070.265-3.1000.8761.4090.534-3.7200.489
Serosal invasionPresent1.4630.670-3.1950.3391.0470.553-1.9840.887
Intrahepatic metastasisPresent1.4710.595-3.6400.4041.5190.752-3.0700.244
Dysplastic nodulePresent0.7440.365-1.5140.4140.8400.478-1.4790.546

  • Citation: Lee SD, Lee B, Kim SH, Joo J, Kim SK, Kim YK, Park SJ. Proposal of new expanded selection criteria using total tumor size and 18F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria. World J Transplant 2016; 6(2): 411-422
  • URL: https://www.wjgnet.com/2220-3230/full/v6/i2/411.htm
  • DOI: https://dx.doi.org/10.5500/wjt.v6.i2.411